GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Shiller PE Ratio

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Shiller PE Ratio : 147.80 (As of May. 14, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Shiller PE Ratio?

As of today (2025-05-14), Zhongyuan Union Cell & Gene Engineering's current share price is ¥22.17. Zhongyuan Union Cell & Gene Engineering's E10 for the quarter that ended in Mar. 2025 was ¥0.15. Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio for today is 147.80.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio or its related term are showing as below:

SHSE:600645' s Shiller PE Ratio Range Over the Past 10 Years
Min: 81.16   Med: 149.21   Max: 991.75
Current: 147.8

During the past years, Zhongyuan Union Cell & Gene Engineering's highest Shiller PE Ratio was 991.75. The lowest was 81.16. And the median was 149.21.

SHSE:600645's Shiller PE Ratio is ranked worse than
91.89% of 148 companies
in the Biotechnology industry
Industry Median: 33.465 vs SHSE:600645: 147.80

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhongyuan Union Cell & Gene Engineering's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.15 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhongyuan Union Cell & Gene Engineering Shiller PE Ratio Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Shiller PE Ratio Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.25 188.67 - 112.57 101.24

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.42 83.68 112.52 101.24 156.59

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio falls into.


;
;

Zhongyuan Union Cell & Gene Engineering Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=22.17/0.15
=147.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongyuan Union Cell & Gene Engineering's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Zhongyuan Union Cell & Gene Engineering's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.06/115.1156*115.1156
=0.060

Current CPI (Mar. 2025) = 115.1156.

Zhongyuan Union Cell & Gene Engineering Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.330 99.500 0.382
201509 -0.530 100.500 -0.607
201512 0.320 100.600 0.366
201603 -0.020 102.200 -0.023
201606 0.057 101.400 0.065
201609 -0.030 102.400 -0.034
201612 0.084 102.600 0.094
201703 0.070 103.200 0.078
201706 -0.050 103.100 -0.056
201709 0.070 104.100 0.077
201712 -0.040 104.500 -0.044
201803 0.350 105.300 0.383
201806 0.460 104.900 0.505
201809 0.060 106.600 0.065
201812 -0.690 106.500 -0.746
201903 0.070 107.700 0.075
201906 0.070 107.700 0.075
201909 0.070 109.800 0.073
201912 -0.100 111.200 -0.104
202003 0.010 112.300 0.010
202006 0.161 110.400 0.168
202009 0.110 111.700 0.113
202012 -0.550 111.500 -0.568
202103 0.100 112.662 0.102
202106 0.140 111.769 0.144
202109 0.170 112.215 0.174
202112 -0.080 113.108 -0.081
202203 0.080 114.335 0.081
202206 0.060 114.558 0.060
202209 0.100 115.339 0.100
202212 0.000 115.116 0.000
202303 0.080 115.116 0.080
202306 0.100 114.558 0.100
202309 0.100 115.339 0.100
202312 -0.050 114.781 -0.050
202403 0.090 115.227 0.090
202406 0.090 114.781 0.090
202409 0.110 115.785 0.109
202412 -0.070 114.893 -0.070
202503 0.060 115.116 0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhongyuan Union Cell & Gene Engineering Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongyuan Union Cell & Gene Engineering Business Description

Traded in Other Exchanges
N/A
Address
45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Executives
Li De Fu Director
Wang Xue Jun senior management
Wang Yong Director
Li Hai Bin Director
He Wei senior management
Li Qiang senior management
Wu Ming Yuan Director
Wang Hui Director
Huang Jia Xue senior management
Cao Hai Feng Director
Han Yue E Director
Liu Yong Jun senior management
Cui Jing Xue Supervisors
Yang Guang Xing senior management
Meng Zhi Hong senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines